Table 2.
(a) Main characteristics of patients stratified by the end-point recurrent angina with need of rehospitalization/revascularization or myocardial infarction. (b) Main characteristics of patients stratified by the end-point mortality.
| (a) | ||||
|
Final Study Cohort
n = 455 |
Angina/Reinfarction
n = 41 (9%) |
No Angina/Reinfarction
n = 408 (91%) |
p Value | |
|
Diagnosis (%) - STEMI - NSTEMI |
60 40 |
36.6 63.4 |
62.3 37.7 |
0.002 |
|
Treatment: - PCI - CABG - Medical treatment |
71.4 11.2 17.4 |
73.2 4.9 22 |
64.8 10.8 15.4 |
0.8 |
| LVEF (%) | 54 (47–60) | 57 (49–61) | 54 (47–60) | 0.14 |
| TnI max (ng/mL) | 12.5 (2.7–52) | 5.78 (1.6–17.2) | 13.9 (2.98–65) | 0.014 |
| Galectin 3 (ng/mL) | 9.8 (7.74–12.3) | 10 (8.07–11.5) | 9.8(7.73–12.34) | 0.8 |
| Galectin 3 binding protein (μg/mL) | 9.07 (5.78–13.44) | 9.1 (7.36–14.2) | 9.06 (5.75–13.4) | 0.55 |
| (b) | ||||
| Total Population n = 469 |
Died
n = 35 (7.5%) |
Alive
n = 434 (92.5%) |
p Value | |
|
Diagnosis (%) - STEMI - NSTEMI |
60.1 39.9 |
57.1 42.9 |
60.4 39.6 |
0.72 |
|
Treatment (%) - PTCA - CABG - Medical treatment |
70.7 11.1 18.2 |
52.9 14.7 32.4 |
72.1 10.8 17.1 |
0.047 |
| LVEF (%) | 52 (47–60) | 43 (39–55) | 55 (48–60) | <0.001 |
| TnI max (ng/mL) | 12.8 (2.9–52.5) | 18.1 (3.6–68.4) | 12.3 (2.6–51) | 0.36 |
| Galectin 3 (ng/mL) | 9.8 (7.77–12.77) | 10.49 (10–15.84) | 9.74 (7.7–12.2) | <0.001 |
| Galectin 3 binding protein (μg/mL) | 9.08 (5.8–13.5) | 10.4 (6.3–16.2) | 9.03 (5.8–13.4) | 0.10 |